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Hemophagocytic syndrome (HPS) is defined by bone marrow
and organ infiltration by activated, nonmalignant
macrophages, which phagocytose blood cells. The clinical
spectrum of HPS is broad, but renal involvement has rarely
been investigated. We report a previously unknown renal
manifestation of HPS: nephrotic syndrome. This multicentric
retrospective study included patients fulfilling the following
criteria: (i) no history of nephropathy; (ii) HPS diagnosis with
histologic evidence of hemophagocytosis; (iii) occurrence of
nephrotic syndrome during HPS; and (iv) available renal
histology. Using the same criteria, we also searched the
literature for additional cases. We identified nine patients
retrospectively and found two additional cases in the
literature (five males and six females, whose mean age was
34727 years). Black African patients predominated (63.6%).
HPS was due to lymphoma (six cases), infectious disease
(three cases), and autoimmune disease (one case), and was
primary in one patient. Acute renal failure was associated
with nephrotic syndrome in 10/11 cases. Renal histology
showed acute tubular necrosis associated with collapsing
glomerulopathy in five patients (all Africans with negative
human immunodeficiency virus serology), minimal change
glomerulopathy in four, and thrombotic-microangiopathy
with abnormal podocytes in two. Death occurred in seven
cases. Nephrotic syndrome should be included among the
renal complications of HPS with acute renal failure. We
postulate that abnormal T-cell activation and/or high
pro-inflammatory cytokine levels during HPS might cause
podocyte injuries, especially among African patients with a
susceptible genetic background.
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Hemophagocytic syndrome (HPS) is a clinicopathologic
entity caused by excessive activation and proliferation of
nonmalignant macrophages. HPS also known as macrophage
activation syndrome, may be either primary, as observed in
various genetic diseases affecting the immune system,
including familial hemophagocytic lymphohistiocytosis,
X-linked lymphoproliferative syndrome, Chediak–Higashi
syndrome, and Griscelli syndrome, or may be secondary to
an underlying disorder, mainly malignancy, severe infection,
or autoimmune disease.1 The manifestations of HPS are the
consequences of widespread tissue infiltration by activated
histiocytic cells, and also result from the secretion of huge
amounts of proinflammatory cytokines by activated T cells
and macrophages.2,3
Clinically, HPS is usually characterized by the combina-
tion of fever, hepatosplenomegaly, lymphadenopathy, and
jaundice, and sometimes by skin rash, lung infiltration, and
hemorrhagic complications of thrombocytopenia. Labora-
tory findings frequently include pancytopenia, liver test
abnormalities, coagulopathy with low fibrinogen levels,
marked hypertriglyceridemia, and elevated serum ferritin.4
The diagnosis of HPS is confirmed by the presence of diffuse
infiltration by well-differentiated macrophages, actively
phagocytosing hematopoietic elements in the bone marrow,
lymph nodes, liver, or spleen (Table 1).5
Since HPS first description in the late 1930s,6 substantial
advances have been achieved in understanding its pathophy-
siology, leading to the identification of a growing number of
cases. However, despite this progress, very few data are
available about the renal complications of HPS. Acute renal
failure is thought to be the most consistent feature4,7 and is
considered by some authors as a strong prognostic factor,8
but biopsy-proven glomerular involvement has remained
poorly documented.
We recently observed three cases of nephrotic syndrome
complicating the course of HPS in the Nephrology Depart-
ment of Necker Hospital. Secondarily, we undertook a
retrospective study and a review of the literature to describe
the glomerular lesions associated with HPS.
RESULTS
Over a 20-year period, nine patients with histologic
examination were retrospectively identified as presenting
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with HPS and nephrotic syndrome. In the literature, only
two previously reported cases fulfilled the criteria stated in
Materials and Methods and were considered for analysis.9,10
The results given below include these two additional cases,
together with the nine new cases that we report.
Characteristics of HPS
Clinical features (Table 2). The study group included 11
patients (five males and six females), whose mean age was
34727 years (range 2.5–68). Patients of Black African origin
predominated (7/11¼ 63.6%). Three of the others were
Caucasians and in one was Chinese.
Only one of the two pediatric patients had a primary HPS
complicating familial hemophagocytic lymphohistiocytosis.
The remaining 10 patients (90.9%) therefore had secondary
HPS, combined with lymphoma in six cases (Hodgkin’s: 1,
T-cell: 4, B-cell: 1). In two cases, HPS was secondary to
infectious diseases (cytomegalovirus infection: 1, visceral
Leishmaniasis: 1), and one case was due to an autoimmune
disorder (pediatric Still’s disease). For the last case (collected
in the literature, patient No. 11), no etiology was identified.
HIV serology was negative in all patients.
The frequency of each HPS symptom among these 11
patients is listed in Table 2. Common initial clinical features
included fever, chills, weakness or fatigue, anorexia, and
weight loss. Six patients (54.5%) exhibited various gastro-
intestinal symptoms, including diarrhea, abdominal pain,
nausea, and vomiting. Four (36.4%) had central nervous
system manifestations, and 4 (36.4%) experienced pulmonary
signs such as cough or dyspnea.
On physical examination, hepatosplenomegaly was found
in four patients (36.4%), superficial lymph node enlargement
in 2 (18.2%), and skin rash in 2 (18.2%).
Laboratory findings. Depression of circulating blood
element counts was the most common laboratory abnorm-
ality. Anemia and thrombocytopenia occurred in 10 patients
(90%) and nine (82%) patients, respectively. The mean nadir
values for hemoglobin and platelet count were 8.371.7 g/dl
and 88 000711 0000 g/l, respectively. All patients (100%) had
depression of at least one cell line. Elevated serum liver
transaminases (alanine aminotransferase and/or aspartate
aminotransferase) and hyperbilirubinemia were present in six
(54.5%) and eight (72.7%) patients, respectively. When
measured, Lactate dehydrogenase, triglycerides, and ferritin
serum were always elevated.
For three patients (No. 2, No. 5, and No. 9), recruited after
the initiation of the study, serum samples collected at the
admission for cytokine measurement were available. A sign-
ificant increase in the serum levels of proinflammatory cytokines
(interferon g, interleukin (IL) 1b, IL6, and TNFa (tumor
necrosis factor alpha)) was observed (Figure 1).
Histologic features. As proved hemophagocytosis was one
of the criteria required for inclusion, it was present in all
patients (100%). However, the diagnostic test that proven its
presence was different from one patient to another.
Bone marrow specimen examination (aspirate and/or
biopsy) was performed in 10/11 patients and was con-
tributive in eight cases. In one of these cases, the first
aspiration smear was normal, so a second aspiration,
performed 2 weeks later, was necessary to confirm the
diagnosis of HPS. In three cases, bone marrow examination
failed to detect hemophagocytosis, but the diagnosis was
confirmed by the biopsy of another organ (skin, lymph node,
and kidney, respectively).
Characteristics of nephrotic syndrome
The clinical features of nephropathy in our patients are listed
in Table 2.
In 7/11 patients (63.6%), nephrotic syndrome and HPS
were diagnosed simultaneously on admission. In three
patients, nephrotic syndrome was diagnosed 25730 days
(range: 4–60) after the diagnosis of HPS. In all three cases,
HPS was active when the nephrotic syndrome occurred. The
remaining patient was initially admitted for nephrotic
syndrome with acute renal failure and HPS was only
diagnosed 12 days later.
Nephrotic syndrome was severe, as assessed by the mean
values for 24-h urine protein and serum albumin, whose
respective levels were 1179.6 g/24 h and 1771.7 g/l.
Acute renal failure was present in 10/11 cases (90.9%), and
oligoanuria in four patients. Dialysis therapy was required
for six patients (54.5%); five of whom had hemodialysis, and
one peritoneal dialysis. Among the 10 patients presenting
with acute renal failure, 4 (36.4%) presented significant
microhematuria.
Renal histology findings
For the nine patients identified retrospectively, renal tissue
for histologic study was obtained from either transcutaneous
renal biopsy (7) or necropsy (2). Table 3 shows the detailed
Table 1 | Diagnostic guidelines for hemophagocytic syndrome (adapted from Henter et al.5)
Clinical criteria Laboratory criteria Histologic criteria
Fever Cytopenias (affecting two or more lineages in the peripheral blood)
Hemoglobin o9 g/dl
Platelets o100 G/l Hemophagocytosis on cytology or histology
Neutrophils o1 G/l
Splenomegaly Hypertriglyceridemia (43 mmol/l) and/or Hypofibrinogenemia (o1.5 g/l)
Diagnosis of hemophagocytic syndrome is considered if five of the above eight criteria are fulfilled.
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histologic features of these patients and of the two reported
in the literature.
Although these features were heterogeneous, all patients
exhibited injuries of the epithelial side of the glomerular
filtration apparatus, which probably accounted for the
nephrotic syndrome.
Glomerular features. Glomerular sampling for light micro-
scopy ranged from 5 to 29 glomeruli (mean: 15), and global
glomerulosclerosis was observed in o5% of the total number
sampled (range 0–16.7%).
Collapsing glomerulopathy was the most frequent light
microscopy pattern, and was observed in five patients
(45.5%), all black Africans. None of them was seropositive
for HIV. Collapsing glomerulopathy was characterized by the
global collapse of several capillary loops with hyperplasic,
swollen, vacuolated podocytes, which had detached them-
selves from the glomerular basement membrane and had
been shed into the urinary space (Figure 2a).
Four patients (36.4%) displayed optically normal glomer-
ular morphology, without proliferation or deposits (Figure
2b). Immunofluorescence microscopy was always negative.
Minimal change glomerulopathy was diagnosed in all four
patients. The diagnosis was further confirmed in one of them
(patient No. 10, from the literature), for whom electron
microscopy was available and showed focal fusion of the
podocyte processes. Although we had no access to the
electron microscopy analysis to confirm the diagnosis of
MCD for the remaining patients, we have biological data to
sustain the diagnosis. We have indeed observed a high
Table 2 | Clinical and laboratory data for 11 patients with HPS associated with nephrotic syndrome
Retrospective study Literature
Patient number 1 2 3 4 5 6 7 8 9 10 11
Age/gender/race 51/M/C 43/M/Af 19/M/Af 60/M/Af 63/F/C 16/F/Af 27/F/Af 7/F/C 68/M/Af 2.5/F/Af 18/F/As
Associated medical conditions None Cardiopathy None
Type II
diabetes HCV Stroke Malaria None
13 relapses
of Still’s Dis None None None
Hemophagocytic syndrome
Etiology of HPS MNHL-T MNHL-T MNHL-T MNHL-B CMV Leish MNHL-T Still’s Dis Hodgkin HLH Unidentified
Fever fatigue/anorexia +/+/+ +/+/+ +/+/+ +/+/+ +/+/+ +/+/+ +/+/+ +/+/+ +/+/+ +/+/+ +/+/+
Gastrointestinal symptoms Absent Absent + Absent + + Absent + + + Absent
CNS symptoms Absent Absent Absent Absent + Absent Absent + + + Absent
Pulmonary symptoms Absent + Absent Absent + Absent Absent + Absent + Absent
Hepato-splenomegaly Absent Absent Absent Absent + + Absent + Absent + Absent
Adenopathy Absent Absent Absent Absent Absent Absent Absent Absent + + Absent
Skin rash + Absent Absent Absent Absent Absent + Absent Absent + Absent
Hemoglobin (g/dl) 12 5.3 8.8 9.6 8.7 6.4 9.4 8 8.5 6.7 7.9
Platelet count (g/l) 30 000 35 000 200 000 45 000 35 000 72 000 387 000 21 800 44 000 37 000 63 000
Elevated transaminases + Absent + + Absent Absent + Absent + NA +
Hyperbilirubinemia + Absent + + + + + + + NA +
LDH (IU/1) 3115 1000 1328 4160 2227 1532 1775 1827 1573 NA 671
Triglyceride (mmol/1) NA NA NA 4.9 5.8 6.4 3.6 2.3 6.3 7.6 3.5
Ferritin (ng/ml) NA NA NA 17 200 8594 552 3230 NA 2800 NA 6640
Hemophagocytosis + + +a + + + +a + +a + +
Nephrotic syndrome
Oliguria NA Absent + + Absent Absent Absent + + NA NA
Creatinine clearance (ml/min) 36 23 11 8 6 8 43 7 3 98 51
Dialysis No No HD HD HD HD No PD HD No No
Proteinuria (g/24 h) 5.7 30 21 5.1 7.3 6 5.6 3.2 25 43 9.6
Serum albumin (g/l) 26 14 11 17 16 18 17 NA 10 NA NA
Microhematuria Absent Absent Absent + + Absent Absent + + 0 +
Steroids Yes Yes No Yes Yes No Yes Yes Yes Yes Yes
Treatment
Cytotoxic agents No CY/VP16 No VP16 No No CY/VP16 VP16 ABVD VP16 No
Iv lg No No No No Yes No No No No No Yes
Outcome Dead Neph S* Dead Dead Dead CRF Cured Dead Dead Dead Cured
Abbreviations: M, male; F, female; C, Caucasian; Af, African; As, Asian; MNHL, malignant non-Hodgkin’s lymphoma; Leish, visceral Leishmaniasis; Still’s Dis, Still’s disease;
FLH, familial lymphohistiocytosis; NA, not available; LDH, lactate deshdrogenase.
aNegative bone marrow examination; HD, hemodialysis; PD, peritoneal dialysis; CY, cyclophosphamide; VP16, etoposide; ABVD, adriamycin+bleomycin+vinblastine+dacarbazine;
Neph S*, patient still nephrotic at 3 months, when lost to follow-up; CRF, chronic renal failure.
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Figure 1 | Serum levels of cytokine at the admission for three
patients with HPS associated with nephrotic syndrome. Proin-
flammatory cytokine levels were measured at the admission for three
patients (No. 2, No. 5, and No. 9) of the series using commercial
immunoenzymatic assay kits (BioSource, Belgium). Each circle
represents single individual, horizontal bars indicate the mean, and
vertical bars denote s.d. In case of IL-2, IL-10, and IL-2R, samples were
available for only one patient. In order to allow the representation of
all the data using the same Y-axis, we normalized the cytokine levels
upon dividing the value measured for each cytokine in each patient
by the maximal normal value for the particular cytokine.
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selectivity index for the three patients of the series with
optically normal glomerular morphology.
Two patients (18.2%) exhibited a similar complex feature,
combining glomerular thrombotic microangiopathy lesions
with evident podocyte damage. Light microscopy identified
mild endocapillary proliferation and obliteration of some
capillary lumina by swollen endothelial cells (Figure 2c).
Chromophore silver methenamine staining produced a ‘double
contour’ appearance. These findings were all consistent with
thrombotic microangiopathy in a subacute stage. However,
light microscopy also showed swollen, vacuolated podocytes,
some of which had undergone detachment from the
glomerular basement membrane (Figure 2d). Immunofluor-
escence staining was negative, except for fibrin on glomerular
capillary thrombi and albumin on damaged podocytes (Figure
2e). Fusion of some foot processes was also noted in one of
these two patients with thrombotic microangiopathy, for
whom electronic microscopy was available.
Tubular and interstitial features. The only patient without
impairment of renal function (No. 10) exhibited normal
tubular histologic features. All the others (10/11, 90.9%)
exhibited the same tubulointerstitial histologic pattern.
Interstitial infiltrates ranged from absent to mild and
consisted of a few localized clusters of mononuclear cells with
interstitial edema (Figure 2g). Immunohistological study
showed that they were mainly constituted of T lymphocytes
with a few B lymphocytes (Figure 2h) and macrophages
(Figure 2i). In only one patient (patient No. 3), intrarenal
interstitial hemophagocytosis was noted. At the outset, it
appears that macrophage infiltration (CD68-positive) is not
necessarily associated with renal involvement during HPS.
The degree of cortical scarring in the form of tubular atrophy
and interstitial fibrosis ranged from none to mild, thus
indicating the acute nature of the renal injury.
In the tubules, severe acute damage was observed by light
microscopy, with the presence of tubular casts and microcystic
tubular dilatation (Figure 2f). Tubular epithelial cells contained
abundant protein reabsorption droplets and showed necrosis with
detachment from the tubular basement membrane (Figure 2f).
Vascular features. Two patients (No. 5 and No. 12)
(18.2%) exhibited thrombotic microangiopathy lesions
affecting both glomeruli and arterioles (Figure 2c). In the
other patients, arterio- and arteriolo-sclerosis ranged from
none (7) to mild (2).
Table 3 | Renal biopsy findings for 11 patients with HPS associated with nephrotic syndrome
Retrospective study Literature
Patient number 1 2 3 4 5 6 7 8 9 10 11
Light microscopy
No. of. glomeruli Necropsy 13 20 22 24 5 8 Necropsy 15 NA NA
No. of sclerotic
glomeruli
NA 1 0 2 4 0 0 NA 2 NA NA
Pattern of
glomerulonephritis
MCD MCD CG CG TMA+podocytosis CG CG MCD CG MCD TMA+podocytosis
Tubular atrophy and
interstitial fibrosis
Mild Absent Absent Minor Mild Minor Absent Absent Mild Absent Minor
Interstitial
inflammation
Absent Minor Mild+a Mild Mild Minor Absent Minor Absent Absent Minor
Tubular damage scale (0 to +++)
Dilatation + ++ +++ +++ ++ +++ +++ ++ +++ Absent NA
Necrosis +++ +++ +++ +++ +++ +++ +++ +++ +++ Absent NA
Protein
reabsorption
droplets
+ + +++ +++ +++ +++ +++ ++ +++ Absent NA
Vascular
damages
Absent Absent Mild Mild TMA Absent Absent Absent Absent Absent TMA
Immuno-fluorescence (scale of 0 to +++)
IgG/A/M 0 0 0 0 0 0 0 0 0 0 0
C3/C1q 0 0 0 0 0 0 0 0 0 0 0
k/l 0 0 0 0 0 0 0 0 0 0 0
Fibrin 0 0 0 0 ++
Glom and
capillary thrombi
0 0 0 0 0 ++ Glom
and capillary
thrombi
Albumin 0 +
Protein
reabsorp
droplets
++
Protein
reabsorp
droplets
+++
Protein
reabsorp
droplets
++
Protein
reabsorp droplets
+++
Protein
reabsorp
droplets
+++
Protein
reabsorp
droplets
0 ++
Protein
reabsorp
droplets
NA NA
Electron microscopy (scale of 0 to +++)
Mesangial
deposits
0 0
Subendothelial
deposits
0 Fluffy
material
Subepithelial
deposits
0 0
Foot process
fusion
+++ +++
Abbreviations: NA, not available; MCG, minimal change glomerulopathy; collapsing G, collapsing glomerulopathy; TMA, thrombotic microangiopathy.
aIntrarenal hemophagocytosis; glom, glomerular; reabsorp, reabsorption.
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Clinical outcome
Clinical follow-up data were available for all patients except
one (patient No. 2), who was lost to follow-up only after 3
months.
Treatment of HPS was in most cases symptomatic but
included steroids in all but two cases. Etoposide (VP16) was
used in five cases, sometimes associated with cyclopho-
sphamide (CY). Only one patient with Hodgkin’s disease
received two full ABVD courses (Table 2).
Death occurred in seven cases (64%). In six of them, it was
attributed to an uncontrolled disseminated hemophagocytic
process, with multiple organ failure. One patient recovered
from HPS after chemotherapy but died 2 months later of
severe Hodgkin’s disease.
Four patients survived HPS (36.4%). Two of them
(18.2%) had no renal sequelae, one patient developed
chronic renal failure and underwent subsequent kidney
transplantation, and the remaining patient was still nephrotic
with normal renal function 3 months after the onset of HPS,
when he was lost to follow-up.
In such a small series, it is extremely difficult to find any
correlation between treatment modalities and renal or patient
survival. Some patients experienced a short remission from
HPS after specific treatment but died from malignant
lymphoma a few days or a few weeks later, before achieving
remission from nephrotic syndrome or recovery from renal
failure. Only two patients who achieved definitive remission
from HPS recovered from both proteinuria and renal
dysfunction, but a third patient, whose leishmaniosis-related
HPS improved after specific treatment, progressed to end-
stage renal disease and required definitive dialysis therapy. No
relationship was found between pathology and outcome.
DISCUSSION
HPS results from the excessive activation and proliferation of
benign macrophages. It can be the consequence of either
hereditary dysfunction of the immune system, or a
complication of underlying disorder including infectious,
neoplastic, or autoimmune diseases. Although the clinical
spectrum of HPS is broad, the renal consequences of HPS
have rarely been described in the literature. Most of the data
on the subject concern the occurrence of acute renal
failure,4,7 sometimes considered as a strong predictor of an
unfavorable outcome.8 The present results are in accordance
with these data as they show a high prevalence of this
complication (90.9%). Histologic data suggest at least two
pathophysiological mechanisms that may be responsible for
the impairment of renal function during HPS: acute tubular
necrosis and/or reduction of the glomerular filtration flow
resulting from the massive collapses of glomerular tufts.
One of the most interesting features of our study was that
it documented the occurrence of previously unknown
glomerular complications of HPS. Thus, we identified nine
cases of nephrotic syndrome associated with HPS, to which
we added two isolated cases reported in the literature. The
clinical presentation was quite similar in all cases, and
consisted of severe proteinuria associated with acute renal
failure occurring during the initial phase of a severe HPS.
The small number of patients identified suggests that this
complication is rare. On the other hand, the fact that three of
the nine cases occurred in a single center over a 6-month
period might also indicate that it may be misdiagnosed,
leading to underestimation of its frequency.
Although the methodology of our study did not allow us
to draw definite conclusions from the results, two arguments
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Figure 2 | Light microscopy and immunofluorescence findings.
(a) Silver staining, original magnification  200: The most common
histologic pattern was collapsing glomerulopathy with global
collapse of capillary loops and hyperplasic, swollen, vacuolated
podocytes, which had undergone detachment from the glomerular
basement membrane and had been shed into the urinary space
(black arrowhead). (b) Masson’s trichrome, original magnification
 200: minimal change glomerulopathy was the second histologic
pattern displayed by the patients with nephrotic syndrome
associated with HPS. It is characterized by optically normal
glomerular morphology, without proliferation or deposit. Two
patients exhibited a complex similar complex feature comprising a
mixture of glomerular thrombotic microangiopathy lesions and
severe podocyte damage. (c) Masson’s trichrome, original
magnification  200: light microscopy identified mild endocapillary
proliferation and obliteration of some capillary lumina by swollen
endothelial cells and fibrin thrombi, which was consistent with
thrombotic microangiopathy in the subacute stage. These two
patients also displayed prominent podocyte injuries. (d) Masson’s
trichrome, original magnification  400: light microscopy showing
swollen and vacuolated podocytes (black arrows).
(e) Immunofluorescence showing strong staining for albumin
beyond the glomerular basal membrane, indicating a major
defect in the glomerular permeability (white arrows). (f) Masson’s
trichrome, original magnification  20 and  40: all patients but
one exhibited severe acute tubular damage. Light microscopy
showed microcystic tubular dilatation and necrosis of tubular
epithelial cells, which underwent detachment from their basement
membrane. Interstitial infiltrates ranged from absent to mild and
consisted of a few localized clusters of mononuclear cells with
interstitial edema. (g) Masson’s trichrome, original magnification
 40. Immunohistological study showed that these interstitial
infiltrate were mainly constituted of polymorphic T lymphocytes
with a few B lymphocytes ((h) anti-CD20, original magnification  40)
and macrophages ((i) anti-CD68, original magnification  40).
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support the hypothesis that HPS was responsible for the
development of the nephrotic syndrome in these patients:
(i) The evolution of proteinuria and HPS were closely
coordinated.
This finding, observed in all patients, was particularly striking
in patient No. 8 (Figure 3), an 8-year-old girl who had been
followed for several years in the Necker-Enfants Malades
Hospital for systemic juvenile chronic arthritis. Despite
prolonged steroid treatment, she had experienced 13 relapses
of arthritis between 4 and 8 years of age. During this period,
her renal function had always been normal and proteinuria
was constantly checked as negative. At the time of the 14th
relapse, she simultaneously developed HPS and acute renal
failure with important proteinuria, requiring temporary
peritoneal dialysis. Remission of the HPS was achieved by
an injection of etoposide (VP16), and resulted in rapid
normalization of renal function and complete resolution of
proteinuria. Nevertheless, HPS recurred 2 weeks later,
together with the sudden onset of nephrotic syndrome and
acute renal failure, revealing minimal change glomerulopathy
and severe acute tubular necrosis.
(ii) In one case published in the literature, the occurrence
of nephrotic syndrome was reported during primary
HPS.10 In this particular situation, the absence of
underlying disease further support the responsibility
of HPS in the genesis of this complication.
Our patients’ renal histology exhibited striking features:
firstly, in all cases, the glomerular injuries, which ranged from
focal fusion of the podocyte processes to the collapse of
glomerular tufts with abnormal podocytes detached from the
glomerular basement membrane, were concentrated on the
epithelial side of the filtration apparatus. Secondly, the
severity of these injuries corresponded to the patient’s ethnic
origin. Thus, only African patients exhibited collapsing
glomerulopathy, and all Caucasian patients minimal change
glomerulopathy. Although, as stated above, the methodology
of this study limited our ability to draw definite conclusions
about the pathogenic processes responsible for the occur-
rence of nephrotic syndrome during HPS, it is tempting to
postulate that a common mechanism targeting the podocytes
leads to variously severe lesions, depending on the patient’s
susceptibility as defined by his genetic background.
As our findings indicate that macrophage infiltration is
not necessarily associated with renal involvement during
HPS, we believe that renal complications result rather from a
systemic cytokine burst, as already documented for other
clinical manifestations of HPS.3 This last hypothesis is
sustained by the very high amounts of circulating cytokines
found in three of the patients (Figure 1). Recent advances in
understanding the pathogenesis of HPS have indeed shown
that it is characterized by a primary uncontrolled T-cell
activation followed by a cytokine burst involving IFN-g,
TNFa, IL-6, IL-1b, and other proinflammatory cytokines.
This physiopathological observation has particular interest in
the case of HPS-related nephrotic syndrome, as the role of
T lymphocyte dysfunction has also been suggested in the
pathogenesis of idiopathic nephrotic syndrome. Experimen-
tal data suggest, indeed, that T-cells could be the source of a
circulating permeability factor leading to the induction of
proteinuria in patients with minimal change glomerulopathy
or focal segmental glomerulosclerosis.11 The nature of this
circulating factor remains elusive, but its identification could
be guided by the study of HPS mechanisms.
Among many potential culprits, TNFa seems to be of
particular interest. TNFa is indeed produced in large
amounts during the acute phase of HPS.1,12 High circulating
levels of this cytokine might explain the podocyte injuries
observed, as previous experimental studies have shown that
TNFa increases the permeability to albumin of isolated
glomeruli13 and induces actin cytoskeleton reorganization in
podocytes.14 The latter phenomenon might account for
detachment of podocytes from the glomerular basement
membrane. Of note, TNFa has also been shown to be
involved in acute tubular necrosis pathogenesis, which is a
common histological feature in the patients experiencing
nephrotic syndrome during the course of an HPS. Other
cytokines could also be, directly or indirectly responsible for
modifications of the glomerular barrier permeability, inter-
fering with the podocyte function or its interaction with the
glomerular membrane. Future studies will possibly lead us to
a common factor involved in both HPS and idiopathic
nephrotic syndrome.
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Figure 3 | Temporal relationship between the HPS and renal
abnormalities for one representative patient of the series
(patient No. 8). Abbreviations: CS, corticosteroid; VP16, etoposide;
w, death of the patient.
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Conclusion
HPS, a disease resulting from excessive activation of non-
malignant macrophages, can be associated with renal
manifestations. Besides acute renal failure, glomerular lesions
can develop in the course of HPS and can lead to the
occurrence of a nephrotic syndrome.
This newly identified severe renal complication of HPS,
which mainly seems to affect Africans, results from the
development of podocyte injuries.
A prospective study is required to evaluate the frequency
of this complication, and the development of animal models
of HPS15 might allow the pathogenesis of the HPS–nephrotic
syndrome association to be clarified.
MATERIALS AND METHODS
Retrospective study
Study population. This retrospective study was conducted in
three Nephrology Departments in the Paris area, over a period of 20
years (from January 1984 to May 2004). To obtain a homogenous
population, inclusion criteria were stringent, as follows:
(i) absence of known nephropathy before the diagnosis of HPS;
(ii) presence of typical HPS, assessed by the diagnostic criteria of
the Histiocyte Society (Table 1),5 including biopsy-proven
hemophagocytosis;
(iii) occurrence of a nephrotic syndrome during the evolution of
HPS; and
(iv) availability of renal histology.
The following definitions were used: nephrotic syndrome, 24 h urine
protein 43.5 g (or 450 mg/body weight for patient under 15 years)
and serum albumin o30 g/l; renal failure, creatinine clearance
(calculated using the Cockcroft and Gault formula) o60 ml/min;
hematuria, 45 red blood cells per high-power field on microscopic
examination of the urinary sediment; oliguria, 24 h urine output
o500 ml.
Patients’ medical records were reviewed for age, gender, medical
history, clinical presentation, renal function, treatments adminis-
tered, and final outcome.
Pathology. All renal tissue samples were processed by standard
light microscopy techniques. Glass slides were prepared and stained
with hematoxylin–eosin and Masson’s trichome. Chromophore
silver methenamine staining was performed to study glomerular
basement membrane structure. Immunofluorescence studies were
performed on 3-mm-thick cryostat sections using polyclonal FITC-
conjugated antibodies against IgG, IgM, IgA, C3, C1q, kappa,
lambda, fibrin, and albumin (Dako, Denmark).
Measurement of cytokine serum levels. For three patients
(No. 2, No. 5, and No. 9), recruited after the initiation of the study,
blood sample for cytokine serum analysis were collected at
admission. Blood tubes were allowed to clot for 1 h at room
temperature, centrifuged at 1500 g for 10 min at 201C, and serum
was stored at 801C until analysis. Quantitative measurement of
IL2, interferon g, IL1b, IL6, IL10, TNFa, and soluble IL2 receptor in
patients’ serum samples was performed using commercial immuno-
enzymatic assay kits (BioSource, Belgium).
Review of the literature
A MEDLINE search was carried out using the following criteria: (1)
all MEDLINE listings as of 09-01-2004 with abstracts; (2) English or
French language; and (3) Humans.
The following phrases were used to query the database: (‘renal’
OR ‘kidney’ OR ‘proteinuria’ OR ‘nephrotic’ OR ‘glomerulopathy’
OR ‘nephropathy’) AND (‘hemophagocytosis’ OR ‘HPS’ OR
‘lymphohistiocytosis’).
The references of each article identified were carefully reviewed
for additional reference.
In all, 50 references were retrieved and screened for the same
inclusion criteria as those used in our retrospective study.
Statistical analysis
Statistical analysis was performed using Stat View software (5.0.1;
SAS Inc., Cary, NC, USA). Owing to the small number of patients,
only descriptive statistics were applied. Results are expressed as
numbers (percentages) for categoric variables, and as means (7s.d.)
for continuous variables.
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